Delirium Monitoring in Neurocritically Ill Patients: A Systematic Review*
Mayur B. Patel(Vanderbilt University Medical Center), E. Wesley Ely(Vanderbilt University), Kate Klein(Futures Group (United States)), Pratik P. Pandharipande(Vanderbilt University Medical Center), Alessandro Morandi(Vall d'Hebron Institut de Recerca), Brenda T. Pun(University of Namur), Andrew M. Naidech(American Heart Association), Arjen J. C. Slooter(University Medical Center Groningen), Yahya Shehabi(UNSW Sydney), Peter E. Spronk(Gelre Hospitals), Jorge I. Salluh(Universidade Federal do Rio de Janeiro), Fernando A. Bozza(D’Or Institute for Research and Education), Josef Bednařík(Eli Lilly (United States)), Patricia Lee(Griffith University), Yoanna Skrobik(Hôpital Maisonneuve-Rosemont), Sayona John(Rush University Medical Center), Annachiara Marra(University of Naples Federico II)
Cited by 108
Related Papers
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
|New England Journal of Medicine|2001|6.1k
Long-Term Cognitive Impairment after Critical Illness
|New England Journal of Medicine|2013|2.8k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Delirium
|Nature Reviews Disease Primers|2020|1.1k